Claudio Cerchion: Discussing the Role of Bispecific Antibodies in Multiple Myeloma at IACH 2026
Claudio Cerchion/X

Claudio Cerchion: Discussing the Role of Bispecific Antibodies in Multiple Myeloma at IACH 2026

Claudio Cerchion, Medical Director of Hematology Unit at IRST IRCCS Meldola, shared a post on X:

“Dear friends, International Academy of Clinical Hematology – was a fantastic meeting, in the wonderful Paris, brilliantly organized by Mohamad Mohty and Arnon Nagler.

I had the opportunity to discuss the role of bispecific antibodies in Multiple Myeloma: the future Will bring more and more personalized treatments! See you next year!”

Claudio Cerchion: Discussing the Role of Bispecific Antibodies in Multiple Myeloma at IACH 2026

Other posts about IACH on OncoDaily.